97 related articles for article (PubMed ID: 32742013)
1. Evaluation of Basal Insulin Dose Reductions in Hospitalized Patients With Diabetes While Unable to Eat.
Petite SE; Huenecke J; Tuttle N
Hosp Pharm; 2020 Aug; 55(4):246-252. PubMed ID: 32742013
[No Abstract] [Full Text] [Related]
2. Comparison of various basal insulin dose adjustments for inpatients while unable to eat.
Eberhard CM; Petite SE
Int J Clin Pharm; 2022 Feb; 44(1):72-78. PubMed ID: 34363191
[TBL] [Abstract][Full Text] [Related]
3. EATING AND GLYCEMIC CONTROL AMONG CRITICALLY ILL PATIENTS RECEIVING CONTINUOUS INTRAVENOUS INSULIN.
Miller EE; Lalla M; Zaidi A; Elgash M; Zhao H; Rubin DJ
Endocr Pract; 2020 Jan; 26(1):43-50. PubMed ID: 31461360
[No Abstract] [Full Text] [Related]
4. Safety and efficacy of continuous insulin infusion in noncritical care settings.
Smiley D; Rhee M; Peng L; Roediger L; Mulligan P; Satterwhite L; Bowen P; Umpierrez GE
J Hosp Med; 2010 Apr; 5(4):212-7. PubMed ID: 20394026
[TBL] [Abstract][Full Text] [Related]
5. CLINICAL CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS CONTINUED ON ORAL ANTIDIABETES MEDICATIONS IN THE HOSPITAL.
Amir M; Sinha V; Kistangari G; Lansang MC
Endocr Pract; 2020 Feb; 26(2):167-173. PubMed ID: 31557075
[No Abstract] [Full Text] [Related]
6. Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease.
Ruiz de Adana MS; Colomo N; Maldonado-Araque C; Fontalba MI; Linares F; García-Torres F; Fernández R; Bautista C; Olveira G; de la Cruz JL; Rojo-Martínez G; Valdés S
Diabetes Res Clin Pract; 2015 Nov; 110(2):158-65. PubMed ID: 26474657
[TBL] [Abstract][Full Text] [Related]
7. BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA.
Bueno E; Benitez A; Rufinelli JV; Figueredo R; Alsina S; Ojeda A; Samudio S; Cáceres M; Argüello R; Romero F; Echagüe G; Pasquel F; Umpierrez GE
Endocr Pract; 2015 Jul; 21(7):807-13. PubMed ID: 26121460
[TBL] [Abstract][Full Text] [Related]
8. Effect of a Standardized Treatment Panel on Hypoglycemic Events in Hospitalized Acute Hyperkalemic Patients Treated With Intravenous Regular Insulin.
Zuern A; Probst LA; Darko W; Rosher P; Miller CD; Gordon L; Seabury R
Hosp Pharm; 2020 Aug; 55(4):240-245. PubMed ID: 32742012
[No Abstract] [Full Text] [Related]
9. Evaluation of Insulin Use and Hypoglycemia in Hospitalized Elderly Patients.
Bach QN; Gilmore RA; Sheffield MC; Hawkins WA
Hosp Pharm; 2017 Dec; 52(11):761-765. PubMed ID: 29276256
[No Abstract] [Full Text] [Related]
10. Comparison of Hypoglycemia and Safety Outcomes With Long-Acting Insulins Versus Insulin NPH in Pregestational and Gestational Diabetes.
Sleeman A; Odom J; Schellinger M
Ann Pharmacother; 2020 Jul; 54(7):669-675. PubMed ID: 31893932
[No Abstract] [Full Text] [Related]
11. Retrospective Evaluation of Glycemic Control With Basal-Bolus or Neutral Protamine Hagedorn Insulin Regimens in Patients Receiving Continuous Enteral Nutrition Therapy in Medicine Wards.
Hijaze D; Szalat A
Nutr Clin Pract; 2017 Aug; 32(4):557-562. PubMed ID: 28760108
[TBL] [Abstract][Full Text] [Related]
12. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
[TBL] [Abstract][Full Text] [Related]
13. [Medical intensive care unit patients with hyperglycemia: is it possible a hypoglycemic risk close to zero?].
Cosmi F; Mariottoni B; Cosmi D
G Ital Cardiol (Rome); 2018; 19(7):460-466. PubMed ID: 29989603
[TBL] [Abstract][Full Text] [Related]
14. COMPARISON OF BASAL INSULIN REGIMENS ON GLYCEMIC VARIABILITY IN NONCRITICALLY ILL PATIENTS WITH TYPE 2 DIABETES.
Haw JS; Farrokhi F; Smiley D; Peng L; Reyes D; Newton C; Pasquel FJ; Vellanki P; Umpierrez GE
Endocr Pract; 2015 Dec; 21(12):1333-43. PubMed ID: 26307899
[TBL] [Abstract][Full Text] [Related]
15. Decreasing the Time to Insulin Administration for Hospitalized Patients With Cystic Fibrosis-Related Diabetes.
Smego A; Lawson S; Courter JD; Warden D; Corathers S
Hosp Pediatr; 2018 May; 8(5):288-292. PubMed ID: 29691278
[TBL] [Abstract][Full Text] [Related]
16. PREVENTION AND MANAGEMENT OF INSULIN-ASSOCIATED HYPOGLYCEMIA IN HOSPITALIZED PATIENTS.
Mathioudakis N; Everett E; Golden SH
Endocr Pract; 2016 Aug; 22(8):959-69. PubMed ID: 27042740
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes.
Herrera KM; Rosenn BM; Foroutan J; Bimson BE; Al Ibraheemi Z; Moshier EL; Brustman LE
Am J Obstet Gynecol; 2015 Sep; 213(3):426.e1-7. PubMed ID: 26070699
[TBL] [Abstract][Full Text] [Related]
18. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.
Pasquel FJ; Gianchandani R; Rubin DJ; Dungan KM; Anzola I; Gomez PC; Peng L; Hodish I; Bodnar T; Wesorick D; Balakrishnan V; Osei K; Umpierrez GE
Lancet Diabetes Endocrinol; 2017 Feb; 5(2):125-133. PubMed ID: 27964837
[TBL] [Abstract][Full Text] [Related]
20. The burden of severe hypoglycemia in type 2 diabetes.
Liu J; Wang R; Ganz ML; Paprocki Y; Schneider D; Weatherall J
Curr Med Res Opin; 2018 Jan; 34(1):179-186. PubMed ID: 29017368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
